Neurotramission in the CNS
- Hierarchical systems
- clear anatomic distribution
- large myelinated rapidly conducting fibres
- control major sensory & motor functions
- Major excitatory neurotransmitter
- aspartate
- glutamate
- inhibitory neurotransmitters
- GABA
- Glycine
- Diffuses systems
- broadly distributed
- divergent
- axons branched and synapses with many cells
- act diffusely far away from site of release
- produce slow and long lasting & diverse effects on NT synthesis, effect on receptors & ionic conductance
- Examples
- NA
- Adrenaline
- Dopamine
- serotonin
- peptides
Synaptic transmission
- Chemical mediators involved in synaptic transmission in CNS
- Neurotransmitter
- substance contained in a neuron, released by presynaptic terminals to produce excitatory/inhibitory responses in postsynaptic neurons
- eg
- acetylcholine
- serotonin
- noradrenaline
- adrenaline
- dopamine
- GABA
- glutamate
- Neuromodulator
- substance that is released by neurons & astrocytes – produces slower pre/postsynaptic responses
- eg
- CO2
- ammonia
- nitric oxide
- Neurotropic factor
- substance released by non-neuronal cells
- act on tyrosine-kinase-linked receptors
- regulate gene expression, control neuronal growth, & phenotypic characteristics
- eg
- growth factors
- cytokines
- chemokines
Neurotransmitter classification
- Classical, non-peptide NT
- Monoamines
- NA. A
- Dopamine
- 5-HT
- Histamine
- Acetylcholine
- Amino acids
- Inhibitory amino acids (IAA)
- GABA
- Glycine
- Excitatory amino acids (EAA)
- glutamate
- aspartate
- Peptide NT
- Substance P
- Opioid peptides
- Others
- Vasopressin
- Oxytocin
- Tachykinins
- CCK
- NPY
- VIP
- Others
- Nitric oxide
- Adenosine
- Cannabinoid
- Purines
- Arachidonic acid
Synthesis, storage, release & fate of neurotransmitters
*Revise from Dr Achike’s foundation 2 notes
_____________________________________________________________________
Neurotransmitter – Criteria for acceptance
- Present in presynaptic terminal
- Synthesised in the neuron
- Precursors
- Tryptophan (for 5-HT)
- Choline (for ACh)
- Presence of rate-limiting enzymatic step
- Enzymes usually in soma and nerve terminals
- following an action potential which causes calcium influx
- same receptors
- enzymatic breakdown
- ACh
- Specific uptake using transporter protein
- NA
- dopamine
- 5-HT
- Once in axoplasm, NT is subjected to enzymatic metabolism
Signalling mechanism for drug effects
- Intracellular receptor
- Transmembrane Enzyme Receptor
- Receptor & Effector on same molecule
- Effector on separate molecule from Receptor
- Ionotropic
- Act on separate effector molecule
- Metabotropic
_____________________________________________________________________
NEUROTRANSMITTERS
Noradrenaline
- Clusters of cell bodies
- in the locus coeruleus (LC) in the brain stem
- Axons project to cortex, hippocampus, cerebellum
- via the medial forebrain bundle
- Other NA neurons lying close to the LC in the pons & medulla
- Nerve terminals release NA diffusely
- Actions
- reward system
- mood
- arousal, attention, learning, memory
- neuroendocrine regulation
- blood pressure regulation
- Actions in CNS
- Generally inhibitory
- Sometimes excitatory
- In LC
- Silent during sleep, increase in activity during arousal/unfamiliar wake-up stimuli
- depending on modd, depressed patients are unresponsive
- Effect of CNS drugs on NA
- CNS stimulants increase wakefulness and alertness
- amphetamine releases catecholamines in brain
- NA Involved in BP regulation
- Clonidine (in the nucleus tractus solitarus) reduce sympathetic outflow from the vasomotor center in the medulla oblongata leading to fall in BP
- Psychotropic drugs
- Excitation (related to biogenic amines)
- Tricyclic antidepressants, coccaine
- block reuptake
- amphetamines
- block uptake, increase release
- monoamine oxid
ase inhibitors - block metabolism
- Sedation/depression
- reserpine
- depletes stores
- clonidine, alpha-methyldopa
- reduce sympathetic outflow
Adrenaline
- Small group of adrenergic neurons with cells bodies
- lying more ventrally to the NA neurons in the brain stem
- their axons run in the pons, medulla and hypothalamus
- important in control of CVS
- Descending fibres which run to the lateral horn of the spinal cord
- increase sympathetic discharge in the periphery
Dopamine
- Cell bodies at all levels.
- Short, median and long axons
- Pathways
- Mesolimbic mesocortical pathway
- reward, motivation, hyperactivity
- increase – schizophrenia
- actions of antipsychotic drugs
- Nigrostriatal pathway
- motor control
- decrease – Parkinson’s
- actions of drugs for Parkinson’s disease
- Tuberoinfundibular/Tuberohypophyseal pathway
- endocrine control
- side effects of antipsychotic drugs
- Receptor families (G-protein coupled receptors)
- D1 family
- subtypes D1, D5
- D2 family
- subtypes D2, D3, D4
- Antipsychotic drugs block D2 receptors
- Clozapine act on D4 receptors
- Important in
- Schizophrenia
- Parkinson’s disease
- ADHD
- Drug dependence & certain endocrine disorders
- Inhibit
- release of prolactin – enchance release of growth hormone
- High concentration of dopamine found in
- basal ganglia
- limbic system
- hypothalamus
- Metabolised by
- MAO –> DOPAC
- COMT and MAO –> HVA
- Reuptake of Dopamine blocked by (block amine transporter)
- cocaine
- amphetamine
- block NA at presynaptic terminal of neuron
- Also stimulates
- chemoreceptor trigger zone (CTZ)
- -> nausea, vomiting
5-HT Systems/Serotonin
- Cell bodies in
- raphe/midline region of the pons & upper brain stem
- axons project diffusely via midbrain bundle to the cortex, limbic system, hypothalamus
- cells at the caudal part of the brain stem project to the cerebellum, medulla and spinal cord
- Functions
- feeding behaviour
- body weight regulation
- hallucinations
- sleep, wakefullness
- mood
- sensory impulse transmission (nociception)
- body temperature, blood pressure, sexual functions
- vomiting
- All receptor subtypes: metabotropic
- except 5HT3-R: ionotropic
- Receptors in CNS
- 5HT1A-R
- limit the firing of cells in raphe & limbic system
- anxiolytics
- antidepressants
- 5HT1B-R and 5HT1D-R
- presynaptic inhibitory receptors in basal ganglia
- 5HT1B-R and 5HT2C-R agonists
- decrease appetite
- 5HT-1D-R agonists (sumatriptan)
- treat migraine
- 5HT2-R
- excitatory postsynaptic effect
- abundant in cortex & limbic system
- target at various hallucinogenic drugs
- 5HT3-R (in area postrema)
- involved in vomiting
- in cortex and brain stem extending to the dorsal horn of the spinal cord
- excitatory in function
- 5HT3-R antagonist
- ondansetron
- used for nause, vomiting
- chemotherapy
- anxiolytic effect
- 5HT4-R (in striatum)
- has presynaptic effect to increase ACh release
- enhance cognition
Summary:
5HT 1 | raphe & limbic system |
5HT 2 | cortex & limbic system |
5HT 3 | cortex & brain stem |
5HT 4 | striatum |
Clinical uses:
5HT 1A-R | Antidepressants |
5HT 1B & 2C-R agonists | Decrease appetite |
5HT 1D-R agonists | Treat migraine (sumatriptan) |
5HT 3-R antagonist | treat nausea & vomiting – chemotherapy (ondansetron) |
Acetylcholine
- Cell bodies at all levels with short & long axons
- basal forebrain –> cortex, interneurons in basal ganglia
- brainstem –> thalamus
- septum –> hippocampus
- Action
- arousal, learning, motor control, memory
- Physostigmine (anti AChE)
- arousal (+ ACh)
- Atropine (muscarinic receptor antagonist)
- sedation (-ACh)
- Hyoscine (muscarinic receptor antagonist)
- amnesia
- Receptors
- Muscarinic-R (G-protein coupled)
- many subtypes
- Agonists
- inhibit ACh release
- Antagonists
- increase ACh release
- Nicotinic-R (ionotropic)
- widespread
- many subtypes
- located presynaptically
- facilitate release of other neurotransmitters (glotamate, dopamine)
- Abnormalities of cholinergic pathways (decrease cognition)
- dementia
- parkinson’s & huntington’s
- dysfunction of many local interneurons in corpus striatum
- associated with motor coordination loss
- alzheimer’s
- degene
ration of neurons in the magnocellular forebrain nuclei - associated with memory loss
Histamine
- Neurons originate in
- magnocellular nuclei in posterior hypothalamus (called tuberomamillary nucleus)
- Widespread distribution
- Action
- arousal
- neuroendocrine regulation
- strongly anti-emetic
- treat nausea, vomiting
- Receptors
- H1
- excitatory
- antagonist: strongly sedative
- H2
- inhibitory
- H3
- excitatory
Amino acid neurotramitters – Glutamic acid (eaa)
- Found in relay neurons at all levels
- 4 receptor subtypes
- NMDA receptor
- excitatory
- blocked by PCP and ketamine
- involved in synaptic plasticity related to learning & memory
- excessive activation following a neuronal injury may cause cell death
- AMPA receptor
- fast EPSP
- wide distribution
- Kainate-receptor
- fast EPSP
- limited distribution
- presynaptc inhibiton
- Metabotropic subtype
- G-protein coupled
- found in pre & post synaptic
- presynaptic: inhibitory
- postsynaptic: excitatory
- involved in synaptic plasticity and excitotoxicity
Amino acid neurotransmitters – GABA
- Main NT mediating IPSP in brain and spinal cord
- 2 receptor subtypes
- GABA-a
- open Cl- channels
- activated by:
- benzodiazepines
- sedative-hypnotic
- anxiolytic
- barbiturates
- gabapentin
- anticonvulsant
- GABA-b
- metabotropic
- coupled to G-protein that either open K+ channels / close Ca2+ channels
- activated by baclofen
Neuropeptides
- Most coexist with classical NT and act together with other NT
- Substance P & glutamate
- used in control of pain
- Examples of neuropeptides
- Opioid peptides
- distributed all over brain & spinal cord
- Presynaptic: inhibitory
- decrease Ca2+ conductance
- decrease cAMP
- Postsynaptic: inhibitory
- increase K+ conductance
- decrease cAMP
- Substance P
- found in type C neurons
- involved in pain/nociceptive sensory pathways in spinal cord
- Comparison between neuropeptides with classical neurotransmitter
- Difference
- synthesis of pro-peptides occur in rough endoplasmic reticulum of the soma
- the processed and secreted in vesicles which are transported via the axon to nerve endings
- during transport, active peptides are generated within the vesicles
- No reuptake /specific enzymes exist for terminating their action
- once empty, vesicles cannot be refilled, but must be replaced with preloaded vesicles
- Similarity
- at nerve terminals, peptides are released via exocytosis in response to increased intracellular Ca2+ / other signals
- effects can be
- excitatory
- inhibtory
- pre/post synaptic
- exerted over short/long distances
- peptides serve mainly as neuromodulators by activating G-protein coupled receptors
- Longer onset of action
Other neurotransmitters & neuromodulators
- Nitric Oxide (NO)
- Purines (ATP, Adenosine)
- Adenosine
- not stored in vesicles
- released by carrier
- Methylxanthines (caffeine, theophylline)
- antogonists of A2 receptors
- cause wakefullness
- Melatonin
- synthesised from 5HT in pineal gland
- Depends on light intensity
- low in the day
- high at night
- Causes sedation and resets biological clock
- medicine for jet lag
_____________________________________________________________________
Drugs acting on CNS
- General
- General anaesthetics
- Selective
- Analgesics, Antypyretics, antiemetics
- Stimulants
- Appetite suppressants
- Antidepressant, antipsychotic
- Drugs for
- epilepsy
- Parkinson’s
- Alzheimer’s
- Migraine
Site & Mechanism of drug actions
- Direct interactions with molecular components of ion channels on axons
- eg. carbamazepine, phenytoin, local anaesthetics, general anaesthetics
- Interaction at synapses (most drugs)
- Presynaptic
- alter synthesis, storage, release, reuptake or metabolism of the neurotransmitter
- Activate/inhibit both pre/post synaptic receptors for specific transmitters
- Interfere with actions of 2nd messengers
CNS drugs are selective, because different groups of neurons use different neurotransmitters. These are grouped into networks with different functions.